Skip to main content

encefalitis/meningitis - CMV (Cytomegalovirus)

Advices

≥ 18 years
Priority Medication Remarks
Priority:
1st choice
Medication:

ganciclovir iv 5mg/kg 2dd 14 to 21 days

≥ 18 years

Indications: Bij verdenking of aangetoonde ganciclovir resistentie of bij ganciclovir toxiciteit

Priority Medication Remarks
Priority:
2nd choice
Medication:

foscarnet iv 90mg/kg 2dd 14 to 21 days

General comments

Voor advies over behandeling en resistentie bepaling kunt u bellen met de dienstdoende viroloog op 06-33331009 (**3431) of via de centrale (buiten kantooruren).

Sources

  1. Pubmed.gov publication # 18582201

    Tunkel et al., The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008 Aug 1;47(3):303-27.

  2. Pubmed.gov publication # 22120594

    Kneen et al., National Encephalitis Guidelines Development and Stakeholder Groups. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect. 2012 May;64(5):449-77.

Antimicrobial resources

The following antimicrobial agents have been used in these recommendations:

External antimicrobial resources
Menu position
Metadata

Swab vid: G-174558.2
Updated: 08/13/2014 - 10:02
Status: Published